S M van der Kooij

A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent‐onset rheumatoid arthritis

Judith A.M. Wessels, S M van der Kooij, Saskia le Cessie et al. · Arthritis & Rheumatism · 2007 · 242 citations

Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis

S M van der Kooij, Y P M Goekoop-Ruiterman, Jeska K de Vries‐Bouwstra et al. · Annals of the Rheumatic Diseases · 2008 · 211 citations · Full text

The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study

Naomi B. Klarenbeek, Melek Güler-Yüksel, S M van der Kooij et al. · Annals of the Rheumatic Diseases · 2011 · 181 citations

A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis

Annette H M van der Helm–van Mil, S M van der Kooij, Cornelia F Allaart et al. · Annals of the Rheumatic Diseases · 2007 · 174 citations

Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study

Naomi B. Klarenbeek, S M van der Kooij, Melek Güler-Yüksel et al. · Annals of the Rheumatic Diseases · 2010 · 163 citations